{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:45:09Z","timestamp":1761630309423},"reference-count":32,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,6,10]],"date-time":"2003-06-10T00:00:00Z","timestamp":1055203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Xenotransplantation"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<jats:italic>Background<\/jats:italic>:\u2002<\/jats:bold> Natural anti\u2010Gal antibodies (NAb) to Gal epitopes play a key role in the rejection of pig cells or organs transplanted into primates. We have investigated the effect on NAb return after extracorporeal immunoadsorption (EIA) of the continuous intravenous (i.v.) infusion of (i) bovine serum albumin conjugated to Gal type 6 oligosaccharides (BSA\u2010Gal) or (ii) a poly <jats:sc>l<\/jats:sc>\u2010lysine backbone conjugated to Gal type 2 or 6 oligosaccharides (PLL\u2010Gal).<\/jats:p><jats:p><jats:bold><jats:italic>Methods<\/jats:italic>:\u2002<\/jats:bold> Porcine mobilized peripheral blood progenitor cells (PBPC) obtained by leukapheresis from MHC\u2010inbred miniature swine (n\u2003=\u20039) were infused intravenously (i.v.) into baboons: <jats:italic>Group 1<\/jats:italic> baboons (n\u2003=\u20034) received whole body and thymic irradiation, splenectomy, antithymocyte globulin, cobra venom factor, cyclosporine, mycophenolate mofetil, anti\u2010CD154mAb, porcine hematopoietic growth factors, and EIA before transplantation of high doses (2 to 4\u2003\u00d7\u200310<jats:sup>10<\/jats:sup>\u2003cells\/kg) of PBPC; <jats:italic>Group 2<\/jats:italic> baboons (n\u2003=\u20033) received the Group 1 regimen plus a continuous i.v. infusion of BSA\u2010Gal for up to 30\u2003days; <jats:italic>Group 3<\/jats:italic> baboons (n\u2003=\u20035) received the Group 1 regimen plus a continuous i.v. infusion of PLL\u2010Gal type 2 (n\u2003=\u20032) or both PLL\u2010Gal types 2 and 6 (n\u2003=\u20033) for up to 30\u2003days.<\/jats:p><jats:p><jats:bold><jats:italic>Results<\/jats:italic>:\u2002<\/jats:bold>  <jats:italic>Group 1<\/jats:italic>: NAb returned to pre\u2010PBPC levels within 20\u201330\u2003days, but there was no induction of antibody to Gal or non\u2010Gal determinants; <jats:italic>Group 2<\/jats:italic>: NAb was undetectable or at very low level during BSA\u2010Gal therapy. In one baboon, however, IgG to Gal type 2, but not to type 6, returned during BSA\u2010Gal therapy; <jats:italic>Group 3<\/jats:italic>: NAb was undetectable or at very low level during PLL\u2010Gal therapy. In two baboons that received PLL\u2010Gal type 2, NAb to Gal type 6, but not to type 2, returned during PLL\u2010Gal treatment. Two of five baboons, however, developed systemic infection. Four of five baboons died within 14\u2003days; autopsy revealed focal hemorrhagic injury to their hearts, lungs, and small intestines, with histologic abnormalities that varied between animals from hemorrhage and\/or thrombosis in some organs (heart, lungs, or intestine) to signs of infections (bacteria in intestine, cytomegalovirus in liver).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> (i) BSA\u2010Gal and PLL\u2010Gal therapy maintained depletion of NAb. (ii) Some heterogeneity in specificity of NAb was identified, indicating that the infusion of a combination of Gal type 2 and 6 glycoconjugates may be required. (iii) The addition of PLL\u2010Gal to the immunosuppressive regimen was associated with a high incidence of morbidity and mortality without a clear histopathologic entity underlying the cause of death.<\/jats:p>","DOI":"10.1034\/j.1399-3089.2003.02078.x","type":"journal-article","created":{"date-parts":[[2003,6,10]],"date-time":"2003-06-10T08:50:52Z","timestamp":1055235052000},"page":"357-367","source":"Crossref","is-referenced-by-count":14,"title":["Depletion of anti\u2010Gal antibodies by the intravenous infusion of Gal type 2 and 6 glycoconjugates in baboons"],"prefix":"10.1111","volume":"10","author":[{"given":"Katsuhito","family":"Teranishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian P.J.","family":"Alwayn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"B\u00fchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Gollackner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Knosalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Huck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Duthaler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Katopodis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henk\u2010Jan","family":"Schuurman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Awwad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.C.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,6,10]]},"reference":[{"key":"e_1_2_21_2_2","first-page":"559","article-title":"Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans","volume":"24","author":"Good AH","year":"1992","journal-title":"Transplant Proc"},{"key":"e_1_2_21_3_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1073\/pnas.90.23.11391","article-title":"Anti\u2010pig IgM antibodies in human serum react predominantly with Gal(alpha 1\u20103)Gal epitopes","volume":"90","author":"Sandrin MS","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_21_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90261-I"},{"key":"e_1_2_21_5_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.2000.00068.x"},{"key":"e_1_2_21_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199901150-00004"},{"key":"e_1_2_21_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199809150-00001"},{"key":"e_1_2_21_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200201150-00024"},{"key":"e_1_2_21_9_2","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.4049\/jimmunol.155.12.5760","article-title":"Clearance pathways of soluble immune complexes in the pig. Insights into the adaptive nature of antigen clearance in humans","volume":"155","author":"Davies KA","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_21_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(99)00103-0"},{"key":"e_1_2_21_11_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.2.1071"},{"key":"e_1_2_21_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200006150-00013"},{"key":"e_1_2_21_13_2","first-page":"173","volume-title":"Handbook of Animal Model in Transplantation Research","author":"Cooper DKC","year":"1994"},{"key":"e_1_2_21_14_2","first-page":"645","article-title":"Peripheral blood progenitor cell mobilization and leukapheresis in pigs","volume":"49","author":"Nash K","year":"1999","journal-title":"Lab Anim Sci"},{"key":"e_1_2_21_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199801270-00005"},{"key":"e_1_2_21_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.1998.tb00018.x"},{"key":"e_1_2_21_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199711150-00005"},{"key":"e_1_2_21_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200011150-00010"},{"key":"e_1_2_21_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703067"},{"key":"e_1_2_21_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199807270-00006"},{"key":"e_1_2_21_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200201150-00004"},{"key":"e_1_2_21_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.1998.tb00038.x"},{"key":"e_1_2_21_23_2","first-page":"549","article-title":"Polymorphism within the human anti\u2010pig repertoire","volume":"28","author":"Goldberg LC","year":"1996","journal-title":"Transplant Proc"},{"key":"e_1_2_21_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1996.tb00862.x"},{"key":"e_1_2_21_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199610270-00018"},{"key":"e_1_2_21_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.1996.tb00119.x"},{"key":"e_1_2_21_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.56.7.1730-1737.1988"},{"key":"e_1_2_21_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200106150-00020"},{"issue":"1","key":"e_1_2_21_29_2","first-page":"152","article-title":"GAS914, a polylysine containing alphaGal, reduces the severity of acute humoral rejection in hDAF pig to primate heterotopic heart xenotransplantation","volume":"1","author":"Manez R","year":"2001","journal-title":"Am J Transplant"},{"issue":"1","key":"e_1_2_21_30_2","first-page":"152","article-title":"The combined effects of pharmacologic neutralization of anti\u2010alphaGal antibodies and complement inhibition on survival of hDAF transgenic pig renal grafts in cynomolgus monkeys","volume":"1","author":"Hausen B","year":"2001","journal-title":"Am J Transplant"},{"key":"e_1_2_21_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03549.x"},{"key":"e_1_2_21_32_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3089.1999.00030.x"},{"key":"e_1_2_21_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200112150-00007"}],"container-title":["Xenotransplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3089.2003.02078.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-3089.2003.02078.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-3089.2003.02078.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:51:21Z","timestamp":1697241081000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-3089.2003.02078.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,10]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1034\/j.1399-3089.2003.02078.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-3089.2003.02078.x","archive":["Portico"],"relation":{},"ISSN":["0908-665X","1399-3089"],"issn-type":[{"value":"0908-665X","type":"print"},{"value":"1399-3089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,10]]}}}